Fitzpatrick, Cella, Harper & Scinto Law Firm Profile

More Profiles:
Choose A Law Firm

on Fitzpatrick, Cella, Harper & Scinto

  • - Financial Information
  • - Compensation
  • - Billing Rates
  • - Lateral Partner Moves
  • - Pro bono
  • - Key Contacts

Fitzpatrick, Cella, Harper & Scinto

  • Designation: New York
  • Head Count: 153
  • Gross Revenues: $104,000,000
  • Revenue Per Lawyer: $680,000
  • Profits Per Partner: $765,000
  • Year Over Year Change: N/A

Fitzpatrick, Cella, Harper & Scinto is a New York-based law firm.  According to the National Law Journal's 2015 NLJ 350 ranking of firms based on size, Fitzpatrick, Cella, Harper & Scinto has 153 attorneys and is the 255th largest firm in the United States.  With $104,000,000 in gross revenue in 2014, the firm placed 194th on The American Lawyer's 2015 Am Law 200 ranking.  The firm has offices in CA, DC and NY.

Firm Rankings

Survey Rank Year Over Year Change Description
Am Law 100 NR N/A Gross revenue
Am Law 200 194 -8 Gross revenue
NLJ 250 238 -2 Lawyer head count
The A-List NR N/A Overall excellence
Pro Bono Scorecard 94 26 Pro-bono commitment
Diversity Scorecard 47 10 Minority head count
Midlevel Associates Survey 70 -21 Job satisfaction
Summer Associates Survey NR N/A Summer programs

In the News

New Associates List

: New Jersey Law Journal : October 16, 2015

IP Boutiques Adjust to Client Use of Patent Office Reviews

Christine Simmons : New York Law Journal : October 05, 2015

The trend of resolving patent disputes in the government's patent office, which costs a fraction of the price of litigation, has had an uneven effect on intellectual property practices across the country.

3 Ways to Meet Biotech Patent Written Description Standards

Christopher Loh and Laura Fishwick : Corporate Counsel : June 23, 2015

Recent Federal Circuit decisions offer guidelines explaining how biotechnology patentees can satisfy the written description requirement.

PTAB: Not a Property Rights 'Death Squad'

Lisa Shuchman : Corporate Counsel : June 01, 2015

A study shows a much more nuanced portrait of the patent appeals board.